| Basic and Diluted Net Loss Per Share |
The following table presents the calculation of basic and diluted net loss per share for the Company’s common stock:
|
|
|
Three months ended September 30,
|
|
|
Nine months ended September 30,
|
|
| |
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021
|
|
|
Numerator
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(31,713
|
)
|
|
$
|
(18,091
|
)
|
|
$
|
(99,302
|
)
|
|
$
|
(65,567
|
)
|
|
Numerator for basic and diluted EPS - loss attributable to common stockholders
|
|
$
|
(31,713
|
)
|
|
$
|
(18,091
|
)
|
|
$
|
(99,302
|
)
|
|
$
|
(65,567
|
)
|
|
Denominator
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
139,542,660
|
|
|
|
136,456,848
|
|
|
|
139,057,663
|
|
|
|
60,104,891
|
|
|
Denominator for basic and diluted EPS - weighted-average common stock
|
|
|
139,542,660
|
|
|
|
136,456,848
|
|
|
|
139,057,663
|
|
|
|
60,104,891
|
|
|
Basic and diluted net loss per share
|
|
$
|
(0.23
|
)
|
|
$
|
(0.13
|
)
|
|
$
|
(0.71
|
)
|
|
$
|
(1.09
|
)
|
|
| Anti-Dilutive Common Equivalent Shares |
Anti-dilutive common equivalent shares were as follows:
| |
|
Three months ended September 30,
|
|
|
Nine months ended September 30,
|
|
| |
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021
|
|
|
Outstanding options to purchase common stock
|
|
|
12,245,302
|
|
|
|
8,126,177
|
|
|
|
12,245,302
|
|
|
|
8,126,177 |
|
|
Outstanding restricted stock units
|
|
|
2,084,710
|
|
|
|
4,861,315
|
|
|
|
2,084,710
|
|
|
|
4,861,315 |
|
|
Outstanding warrants
|
|
|
3,968,319
|
|
|
|
3,968,319
|
|
|
|
3,968,319
|
|
|
|
3,968,319 |
|
| |
|
|
18,298,331
|
|
|
|
16,955,811
|
|
|
|
18,298,331
|
|
|
|
16,955,811 |
|
|
|